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Abstract
Background: Although the entire duration of fetal development is generally considered a highly susceptible period, it is of
public health interest to determine a narrower window of heightened vulnerability to polycyclic aromatic hydrocarbons
(PAHs) in humans. We posited that exposure to PAHs during the first trimester impairs fetal growth more severely than a
similar level of exposure during the subsequent trimesters.
Methods: In a group of healthy, non-smoking pregnant women with no known risks of adverse birth outcomes, personal
exposure to eight airborne PAHs was monitored once during the second trimester for the entire cohort (n=344), and once
each trimester within a subset (n=77). Both air monitoring and self-reported PAH exposure data were used in order to
statistically estimate PAH exposure during the entire gestational period for each individual newborn.
Results: One natural-log unit increase in prenatal exposure to the eight summed PAHs during the first trimester was
associated with the largest decrement in the Fetal Growth Ratio (FGR) (23%, 95% Confidence Interval (CI), 25t o20%),
birthweight (2105 g, 95% CI, 2188 to 222 g), and birth length (20.78 cm, 95% CI, 21.30 to 20.26 cm), compared to the
unit effects of PAHs during the subsequent trimesters, after accounting for confounders. Furthermore, a unit exposure
during the first trimester was associated with the largest elevation in Cephalization Index (head to weight ratio) (3 mm/g,
95% CI, 1 to 5 mm/g). PAH exposure was not associated with evidence of asymmetric growth restriction in this cohort.
Conclusion: PAH exposure appears to exert the greatest adverse effect on fetal growth during the first trimester. The
present data support the need for the protection of pregnant women and the embryo/fetus, particularly during the earliest
stage of pregnancy.
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Introduction
Polycyclic aromatic hydrocarbons (PAHs) are multiphasic fused
aromatic rings of carbon compounds. Ubiquitous human
dependence on combustion of carbon-containing materials—
primarily fossil fuel—has contributed to PAH air pollution as a
global issue [1,2,3]. Some PAHs are potent mutagens, genotoxins
and known human carcinogens [4].
Transplacental mutagenicity and genotoxicity of some PAHs
are well established in several experimental animal species [5,6].
For example, in utero exposure of mice to benzo[a]pyrene (B[a]P)
and dibenzo[a,l]pyrene could induce the formation of DNA-
adducts in thymocytes and splenocytes of the offspring [7]. Such
adducts are vital precursors to PAH-mediated carcinogenesis [7].
In utero PAH exposure could also induce lung and liver tumors, as
well as lymphoma in mice offspring [8,9,10].
In humans, maternal exposure to certain carcinogenic PAHs (c-
PAHs) during pregnancy could induce DNA damage, histone
modification, and chromosome abnormalities in the fetus [11] at
an environmentally relevant exposure range. PAH-DNA adducts
have been detected in human fetal umbilical cord blood DNA, as
well as in maternal blood after exposure to ambient airborne
PAHs [12]. Prenatal PAH exposure quantified using personal air
monitoring significantly predicted dose-responsive elevation in
chromosomal aberrations in cord blood [13]. Accordingly,
prenatal PAH exposure may increase cancer risk in humans.
Furthermore, prenatal exposure to PAHs through maternal
inhalation is associated with a wide range of non-carcinogenic
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small-for-gestational age [15], and preterm delivery [15]. When
the prenatally monitored group of newborns was followed to
school age, the prenatal PAH exposure furthermore impaired
neurodevelopmental performances [4], and increased the likeli-
hood of asthma-related symptoms [11].
However, to date, the precise window of fetal susceptibility to
the airborne PAHs on adverse birth outcomes has never been
directly examined in human populations. The importance of this
question stems from the observed variability in transplacental
fetotoxic effects according to the gestational window of exposure in
several animal models [8,16,17]. Thus, not only the concentration
and the components of the PAH mixture in air, but also the fetal
age, might influence the type and the severity of adverse clinical
health outcomes in humans.
The goal of the present analysis is to address this critical gap in
knowledge. Several lines of experimental and clinical evidence
suggest that the embryo/fetus is most vulnerable to a number of
PAHs during the first trimester, or the period of organogenesis.
Two modes of PAH effects have been identified during the earliest
gestational weeks, the first being the interference with placental
development [18,19,20], and the second being direct injury of the
embryo. In the first mechanism, PAHs, in particular B[a]P, disrupt
early trophoblast endovascular proliferation and their ability to
infiltrate into the fetal envelope [21]. Such proliferative failure
results in an altered vascular labyrinthine structure of the placenta,
a lowered fetoplacental vascular surface area, and altered
apoptosis in fetal endothelia and syncytiotrophoblast cells
[10,22]. This critically impairs the development of several vital
fetal organ systems, including the central nervous systems and the
heart, as they undergo terminal cell lineage commitment during
this period [10,22]. In the second mode of PAH fetotoxicity, the
direct impairment of embryonic growth differs with the gestational
age of exposure as well as the target organs [17]. For example,
B[a]P administration in the patas monkey model has shown that
the fetal brain is most vulnerable to B[a]P DNA adduct formation
during the first trimester, while the fetal liver is most vulnerable to
the same adducts during the second trimester [17].
A small body of epidemiological evidence suggests that ambient
PAH concentrations pose the greatest risk during the first
trimester. In Teplice, Czech Republic, an area noted for high
environmental pollution, exposure of pregnant women to high
ambient concentration of c-PAHs and PM10 during the first
gestational month was associated with significantly increased risk
of intrauterine growth restriction [14,23].
Considering both biological and epidemiological evidence, we
tested the hypothesis that an embryo/fetus is most vulnerable
during the first trimester per unit PAH exposure, compared to a
comparable unit of exposure during the second or the third
trimester in a cohort of non-smoking, healthy pregnant women.
We examined this by 1) using a newly developed model to estimate
personal exposure to airborne PAHs during the entire gestational
period for each newborn; 2) comparing the birth outcome effect
sizes per unit PAH exposure during given window of interest (i.e.
trimester or gestational month) to those during other periods,
including the sixth gestational month as the reference period; 3)
examining whether the gestational period of IUGR onset is
associated with an IUGR subtype as well as its severity.
Methods
Site Characterization
In a prospective birth cohort study, pregnant women were
recruited from prenatal care clinics during their first trimester in
Krakow, Poland. In the city of Krakow, coal combustion for
domestic heating represents the major air pollution source [24]. In
contrast, automobile traffic emissions and coal-combustion for
industrial activities are relatively minor contributors [24]. During
typical winter days in 2005, ambient PM10 concentrations in
Krakow have been shown to peak at 400 mg/m
3 [24]. During such
episodes, ambient B[a]P and other PAHs were spatially homoge-
neous in their concentrations over the city, suggesting that the
city’s population could have been exposed to a narrow range of
concentrations [24].
Study Subjects
Details regarding subject enrollment and methods are discussed
elsewhere [25]. We targeted Caucasian pregnant women of ethnic
Polish background during the 8
th to 13
th weeks of gestation. To
reduce confounding, only young (age, 18–35) and healthy women
with no known risks for adverse birth outcomes were eligible.
Those who met all the eligibility criteria were simultaneously
monitored for their personal (n=344), home indoor (n=76), and
outdoor (n=70) levels of PAHs and PM2.5 during the second
trimester of pregnancy between November 2000 and January
2003 [25]. The women also answered a questionnaire on health,
lifestyle and exposure history. In the subset of women (n=77), they
were monitored for their personal exposure, in addition to the
indoor and outdoor monitoring of PAHs. In the subset, personal
monitoring was repeatedly taken once during each trimester (see
Table S1). For personal monitoring, each woman carried her a
personal air monitor which operated for a consecutive 48-hour
period. The split flow inlet, placed near the woman’s breathing
zone, drew in the particulate or semi-volatile vapor PAHs and
particles #2.5 mm (PM2.5) on a pre-cleaned quartz microfiber
filter and polyurethane foam backup. The filters were analyzed for
pyrene and eight PAHs known to be carcinogenic as well as having
othertoxicities:benz(a)anthracene,chrysene/isochrysene,benzo(b)-
fluoranthene, benzo(k)fluoranthene, benzo(a)pyrene, indeno(1,2,3-
cd)pyrene, dibenz(a,h)anthracene and benzo(g,h,i)perylene.
Full enrollment criteria required the completion of a prenatal
interview, compliance with air monitoring with minimal problems
in data quality, and the donation of a maternal and/or newborn
cord blood sample at delivery. The cotinine concentration
(0.31960.882 ng/ml serum, mean 6 S.D.), which was available
for 228 newborns, indicated no secondhand smoke exposure
($15 ng/mL) in women up to 48-hours prior to delivery. The
study was reviewed and approved by the institutional review
boards of Jagiellonian University in Krakow and Columbia
Presbyterian Medical Center, New York City, US. Written
informed consent was obtained from all study participants.
Outcomes
In addition to abstracting birthweight (g), birth length (cm) and
birth head circumference (cm) from the medical record, we
calculated fetal growth ratio (FGR, %), Cephalization Index (cm/
g), and Ponderal Index (g/cm
3) for each newborn. In order to test
our main hypothesis, we chose fetal growth restriction (FGR) as a
marker for symmetric IUGR because of its clinical predictiveness
of neonatal morbidities [26], advantage in linear regression
analysis, and its consistency with small for gestational age (SGA)
outcome in our New York City birth cohort [15]. FGR indicates
percent underweight relative to the population mean [26].
Moderate to severe (i.e. ,80%) FGR has been associated with a
greater risk of delayed neurodevelopment [27,28], shorter stature,
cardiovascular disease, insulin resistance and diabetes during
adulthood [29]. In order to meet our third specific aim of detecting
severe IUGR subtypes, we chose two indices of asymmetric fetal
Fetal Window of Susceptibility to Air Pollution
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Cephalization Index has been validated as a marker for a severe
IUGR subtype for an impaired fetal brain development [26]. Ten-
year old children born with larger head size relative to their body
weight (i.e. ‘‘brain spared’’) scored significantly lower in neurode-
velopmental tests, intelligence quotient, and school performance
[30]. In a murine model, fetal cranium and neural tissues are most
exquisitely sensitive to PAHs during the period of organogenesis
[31]. Accordingly, we speculated that onset of PAH-mediated
impairment in fetal neural tissues occurs in late first to early second
trimester. On the other hand, the Ponderal Index was chosen
because earlier epidemiologic studies observed that the SGA
newborns who were particularly ‘‘thin’’ were at a greater risk of
perinatal asphyxia and extended hospitalization, compared with
the proportional SGA cases [32]. Low Ponderal Index further-
more predicted shorter stature, cardiovascular disease, insulin
resistance, and diabetes during adulthood [29]. As fetal weight
gain is highest during the third trimester, such impairment is
expected to result in low Ponderal Index [33]. Accordingly, we
posited that the Ponderal Index captures an acute IUGR
phenomenon with the third trimester as the time point of onset.
The Ponderal Index was calculated as [birthweight (g)/(birth-
length)
3 (cm)
36100] [32]. The Cephalization Index was calculated
as the ratio of the [birth head circumference (mm)/birthweight (g)]
[30]. FGR was calculated as observed birthweight/mean birth-
weight at a given gestational age and gender based on 1994–1996
Polish birthweight distribution [34]. Cephalization index has been
validated as a marker for a severe IUGR subtype [26].
Statistical Analysis
As in prior analyses, the main exposure variable was calculated
as a summed concentration of the eight carcinogenic PAHs (S8c -
PAHs) [35]. The exposure unit of interest was a one natural-log
(ln) unit increase in concentration of S8 c-PAHs.
Personal Exposure Concentration Prediction. We
considered 48-hour personal exposure monitored data in the
overall cohort and the subset (see Table S1) in order to predict
chronic prenatal exposure of the same newborns during the
unmonitored periods. Each individual newborn’s exposure to S8
c-PAHs over the entire gestational period was estimated using two
approaches – a random effects model and a semi-parametric
mixed effects model.
First, based on our earlier analysis [25], the individual
newborn’s chronic prenatal exposure was estimated using a
random effects model as shown below in [1].
ln(
X
8c -PAHs)ij~bi1z(bi2|tij)zXT
ijbzeij: ð1Þ
Personal exposure to ln(
P
8c -PAHs)ij for the ith subject at the
jth measurement was modeled as a function of the random
intercept (bi1), the product of random slope (bi2) and calender time
tij, and a vector of other covariates, which are time-independent
(e.g., living in City center, secondhand smoke exposure), denoted
as XT
ijb. The measurement error is noted as eij. The superscript
T
represents the vector of each covariate, and b the associated
regression coefficient. Here, bi1, bi2 and eij are expected to be
normally distributed with a mean of 0. By including both random
intercept and random slope, the predicted individual PAH
exposure trajectory not only shift from the population mean curve
by a subject specific amount, bi1, but also has a subject specific
slope, bi2. To reduce within-person collinearity in predicted
personal exposure, mean over three months period of personal
exposure to ln(
P
8c -PAHs)ij was taken for each person during
each trimester.
Alternatively, we estimated individual’s chronic gestational
exposure using a semi-parametric mixed model [25] as shown in [2].
ln(
X
8c -PAHs)ij~bi1z(bi2|tij)zXT
ijbzft ij
  
zeij: ð2Þ
Personal exposure to ln(
P
8c -PAHs)ij for the ith subject at the jth
measurement was modeled as a function of the random intercept
(bi1), the product of random slope (bi2) and calender time tij, and a
vector of other time-independent covariates (i.e., living in city center,
secondhand smoke, parity, maternal pre-pregnancy body mass
index, gestational age, newborn gender, and c-section delivery for
birth head circumference and Cephalization Index only) (XT
ij b),
where
T stands for a transpose of a vector of the covariates, and b
denotes the corresponding coefficients. The nonlinear trend in
ambient PAH levels was captured by a fully nonparametric function,
f(tij). Term, eij, denotes a measurement error. The distributions of
bi1,bi2 and eij wereassumed to be normal with a mean of0. Overall,
the semi-parametric model yielded more precise predicted concen-
trations of personal exposure than the estimates using the linear
mixed effects model during each gestational month (see Figure S1).
Considering the observed cohort’s mean personal exposure
throughout the monitoring period as the gold—standard, Pearson’s
coefficients between predicted and observed personal exposurelevels
were 0.91, 0.98 and 0.96 for the third, sixth and the eighth
gestational month using semi-parametric mixed model (Figure S1).
In comparison, the linear mixed effects model, Pearson’s coefficient
between predicted and observed concentration was 0.76 during the
sixth gestational month.
Parametric Analysis of the Birth Outcomes. Functional
linear models of the i
th subject’s birth outcome is shown as,
Birth Outcomei~
ðTdeliveryi
0
ln
X
8 c{PAHs
  
i
s ðÞa s ðÞ z~ x xT
i ~ b bzei,
ð3Þ
where the fetal growth is a function of the integrated chronic
exposure between conception and delivery,
Ð Tdeliveryi
0 ln
P
8 c{PAHs ðÞ i s ðÞa s ðÞ , and other time-
independent, potential confounders (i.e., gestational age,
newborn gender, parity, and the mother’s pre-pregnancy body
mass index) ~ X XT
i ~ b b
  
, and measurement error (ei) [36]. Here,
s ðÞa s ðÞdenote instantaneous time unit and the coefficient curve,
respectively. The measurement error (ei) is assumed to be
distributed normally with mean 0.
Non- Parametric Analysis of the Birth
Outcomes. Indicator variables for the season during each
given gestational month were used as a proxy of maternal
exposure to PAHs. Our prior observations demonstrated that the
season of PAH monitoring is a precise and accurate indicator of
personal exposure (R
2=0.74; all regression coefficients .0.96)
[25]. The calendar months between conception and delivery dates
were calculated based on last menstrual date- or sonogram-based
gestational age [35]. To preclude multicollinearity in the birth
outcome models, the indicator variables were calculated for each
newborn’s first, third and the last gestational month. The season
during given gestational month was coded as winter if it
corresponded to the months December–February. The
remaining calendar months were set as the reference.
Fetal Window of Susceptibility to Air Pollution
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ZT
i   d dzln
X
8 c{PAHs
   sixth gestational month
i
z~ X XT
i ~ b bzei:
ð4Þ
Here, Z represents a vector of the winter indicator variable during
the first, third, and the ninth gestational months, and   d d represents
the respective regression coefficients. Since personal air
monitoring was conducted in all women in the cohort during
sixth gestational month, we accounted for this with the term,
ln
P
8 c{PAHs ðÞ
sixth gestational month
i .
Cross-Validation of the predicted PAH exposure. The
prediction ability of our final model for a future observation is
evaluated using ‘‘leaving-one-out’’ strategy of cross validation.
Specifically, we fit the model with one observation deleted at each
time and use that observation as the test sample to calculate the
prediction error, defined as the difference square between
observed and predicted. We do this for each observation and
average the prediction error over. That is, we calculate
CV~n{1 X n
i~1
fYi{^ Y Y
{i ðÞ
i g
2 ð5Þ
where Yi denote the observed outcome of the i
th observation and
^ Y Y
{i ðÞ
i denote the predicted outcome of that observation with
regression applied to the data with Xi,Yi ðÞ deleted. The statistical
analysis was conducted in R, version 2.5.1 [37], SAS version 9.1.3
(SAS Institute Inc., Cary, NC, USA), and PASW Statistics version
14.0 (SPSS Inc., 2009, Chicago, IL, USA). Figures were generated
in R 2.5.1 and PASW Statistics version 14.0.
Results
The demographic characteristics of the mother-newborn pairs
are shown in Table 1. The majority of the pregnant women did not
have any risk factors for adverse birth outcomes (e.g., secondhand
cigarette smoke, low educational attainment, or absence of spouse
during the present pregnancy) or other sources of PAH exposure
(i.e. routine consumption of grilled/barbecued food).
The prevalence of preterm delivery (4.7%, n=16) and low
birthweight (0.6%, n=2) was low. Overall, mean FGR (mean 6
S.D., 104612%, range, 70–149%) and mean Ponderal Index
(mean 6 S.D., 2.1160.21, range, 1.60–3.12) suggest that the
birthweight distribution of the present cohort were comparable to
the Polish population means. In this cohort, FGR demonstrates a
high internal validity as a summary index of IUGR, and is
consistent with trends in birthweight, birth length, birth head
circumference, and Cephalization Index (Table 2). The severity of
FGR was inversely correlated with the Cephalization Index
(Pearson’s coefficient=20.68, p-value,0.001). At the same time,
severe FGR newborns (,75%) were not significantly thinner (i.e.
lower Ponderal Index) than non-FGR newborns (Table 2).
I. Estimated Personal Chronic PAH Exposure
Consistent with our earlier analysis [25], the three illustrative
subjects shown in Figure 1 demonstrate that their chronic
individual-level of exposure is predominantly influenced by
ambient PAHs. The same subjects show that within-person
variability in the estimated PAH exposure across the seasons was
markedly larger than the between-person variability in the
estimated PAH exposure during a same season (Figure 1).
Prediction error between the predicted vs. observed exposure to
S8 c-PAHs was 0.43 for the 344 newborns (see Figure S1).
II. Mean PAH Effect Sizes by Trimester on Symmetric Fetal
Growth Restriction
a. Random Effects Model-Estimated PAH Exposure and
Mean Effect By Trimester. Using random effects model, one
ln-unit exposure to S8 c-PAHs during the first trimester was
associated with the largest mean reduction in FGR (23%, 95%
CI, 25t o20%), compared to the mean reduction during the
second or the third trimester (see Figure 2).
In addition, the same unit increase in exposure was associated
with the largest mean reduction in birthweight during the first
trimester (2105 g, 95% CI, 2188 to 222 g), compared to the
second (236 g, 95% CI, 276 to 4 g), or the third trimester
(244 g, 95% CI, 2123 to 36 g). For the birth length, a one ln-unit
increase in exposure during the first trimester was associated with
the largest mean reduction (20.78 cm, 95% CI, 21.30 to
20.26 cm) compared to the same unit of exposure during the
second trimester (20.24 cm, 95% CI, 20.49 to 0.01 cm) or
during the third trimester (20.57 cm, 95% CI, 21.07 to
20.07 cm). However, one ln-unit of exposure was associated with
a similar reduction in birth head circumference during the first
(20.11 cm, 95% CI, 20.39 to 0.17 cm) and the second trimesters
(20.13 cm, 95% CI, 20.26 to 0.00 cm). All models controlled for
the mother’s pre-pregnancy body mass index, gestational age,
gender and parity.
b. Semi-Parametric Mixed Effects Model-Based Exposure
Estimation. Figure 3 shows the point-wise PAH effect on FGR
throughout the gestational period. Within this cohort, the
newborns that experienced their highest exposure during the
earliest gestational weeks were associated with the largest point-
wise FGR decrement, compared to other newborns that
experienced lower exposure during the same period. Among the
full-term newborns, a high ambient PAH concentration during the
earliest gestational weeks is positively correlated with an elevated
exposure during the last gestational months due to seasonal trend.
Thus, a unit of PAH exposure during the first four (or, the last
four) gestational weeks is associated with a largest reduction in
FGR. Using the semi-parametric exposure estimation approach, a
unit of PAH exposure during the first gestational month was
associated with a mean reduction in FGR of 0.244% (95% CI,
20.574, 0.086%), compared to the effect size during the reference
period (6
th month). Similarly, a unit PAH exposure during the 9
th
gestational month was associated with a 0.178% (95% CI, 20.558,
0.201%) reduction in FGR after adjusting for the effects during
other gestational months.
c. Non-parametric Comparison of ambient PAH Levels
and Birth Outcomes. Compared to the newborns who
experienced winter during their 6
th gestational month, those that
experienced winter (December–February period) during their 1
st
gestational month had a significantly larger reduction in
birthweight (2191 g, 95% CI, 2316 to 267 g), birth length
(21.14 cm, 95% CI, 21.93 to 20.35 cm) and FGR (25%, 95%
CI, 9 to 22%) respectively. The models accounted for the same set
of potential confounders (Table 3).
III. Prenatal PAH Exposure and Asymmetric Fetal Growth
Restriction
One ln-unit g8 PAHs during the first trimester (using random
effects model for prediction of chronic exposure) was associated
with the largest mean elevation in Cephalization Index (3 mm/g,
95% CI, 1 to 5 mm/g), adjusting for the same set of confounders
(Figure 4). Based on the semi-parametric exposure estimation
method, the first month’s exposure was associated with a highest
point-wise elevation in Cephalization Index (0.22 mm/g, 95% CI,
20.04, 0.48 mm/g), compared to the ratio during the 6
th month
Fetal Window of Susceptibility to Air Pollution
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duringtheearliestandthelastgestationalmonthsarecorrelated,the
same unit exposure was also associated with an elevation in
Cephalization Index (e.g., 0.05 mm/g) during the 9
th month.
Alternatively, based on consideration of non-parametric indicators,
the newborns who experienced winter (December–February)
during their 1
st gestational month, on average, had the largest
elevation in Cephalization Index (5 mm/g, 95% CI, 1 to 8 mm/g),
compared to the newborns who experienced winter during their 6
th
gestational month (Table 3). On the other hand, prenatal PAH
exposure was not associated with a significant reduction in Ponderal
Index during any gestational period (Figure 6).
Discussion
The identification of a ‘‘window of critical vulnerability’’ to
ubiquitous air pollutants such as PAHs is a particularly important,
yet challenging, question. Critical hurdle with answering this
question regards the dose-response relationship of the xenotox-
icant during a given age, which is inherently related to the host’s
susceptibility as well as the host’s adaptiveness. Such exquisite
sensitivity of the fetus and newborn to xenotoxicants is thought to
be related to the immaturity of the developing immune systems;
the rapid development of fetal organs; epigenetic mediation; and
the fact that exposure per body weight is much higher than for
adult exposure [38,39,40]. Thus, the age-specific measurement of
PAH exposure is critical for the clarification of the severity and the
type of IUGR [10,22].
The present analysis supports the hypothesis that PAH exposure
during the first trimester imparts the largest reduction in the
markers of symmetric fetal growth restriction. Furthermore, we
originally posited that elevated Cephalization Index represents a
marker of asymmetric growth. However, our results suggest that it
is, in fact, correlated with a symmetric fetal growth restriction.
Prenatal PAH exposure during the earliest gestational months was
associated with a consistent effect on Cephalization Index and
FGR. Also, we saw no evidence that PAH exposure increases the
Table 1. Demographic and exposure characteristics of mother-newborn pairs.
Characteristics N (%) Mean 6 S.D.
Mother’s characteristics
Age [years] 344 (100%) 2864
Annual household income
a
Low ,37,024 PLN 232 (67.4%)
Medium 37,024–74,048 PLN 16 (4.7%)
High .74,048 PLN 1 (0.3%)
Refused/Don’t know 95 (27.6%)
Education
,high school 37 (10.8%)
high school graduate 91 (26.5%)
Attained.high school 216 (62.8%)
Parity [yes] 126 (36.6%)
Currently married [yes] 320 (93.0%)
Routinely consumed high level of PAH-laden food items
b 49 (14.2%)
Pregnant women with daily alcohol intake
c 4 (1.2%)
Season of delivery
Winter (Dec–Feb) 85 (24.7%)
Spring (March–May) 94 (27.3%)
Summer (June–Aug) 90 (26.2%)
Fall (Sep–Nov) 75 (21.8%)
Secondhand cigarette smoke
Non-smoker home 286 (83.1%)
Exposed to #4 hrs/day 46 (13.4%)
Exposed to 5+ hrs/day 12 (3.5%)
Newborn characteristics
Gender [female] 175 (50.9%)
Newborn cotinine (ng/ml) 228 (66.3%) 0.31960.882
Birthweight (g) 34306491
Birth length (cm) 5563
Birth head circumference (cm) 33.9361.48
aFor 2003, 1 US dollar was equal to 4.07 Poland Zlotych (PLN).
bReported taking at least one smoked, grilled or barbequed food .twice/wk.
cDrank at least one glass of wine, beer, or liquor per day during pregnancy.
doi:10.1371/journal.pone.0035464.t001
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Ponderal Index.
The strong inverse correlation between FGR and Cephalization
Index in our results is also supported by similar results in the
murine model [16]. B[a]P administration during organogenesis
interfered with preliminary synapse formation during the earliest
weeks of gestation and induced the largest disproportionate
increase in Cephalization Index [16]. Furthermore, gestational
B[a]P exposure postnatally inhibited the cortical region for
learning and memory [16].
Table 2. Correlation between fetal growth ratio with other anthropometric indicators
a.
fetal growth ratio (%)N Birthweight [g] Birth Length [cm]
Birth Head Circumference
[cm]
Ponderal Index [g/
cm
36100]
Cephalization
Index [mm/g]
Mean 6 SD Mean 6 SD Mean 6 SD Mean 6 SD Mean 6 SD
(min – max) (min – max) (min – max) (min – max) (min – max)
Non-case 326 34826436 5563 34.0761.34 2.1260.21 99611
(fetal growth ratio
$85%)
(2150–4700) (46–64) (31.00–39.00) (1.60–3.12) (74–153)
Mild 11 26576231 5162 31.9160.70 1.9660.20 121612
(80–84.99%) (2210–2850) (50–55) (31.00–33.00) (1.68–2.27) (109–145)
Moderate 2 22256460 4863 31.5060.71 2.0060.06 144627
(75–79.99%) (1900–2550) (46–50) (31.00–32.00) (1.95–2.04) (125–163)
Severe 3 21906295
** 4863
** 30.6760.58
** 2.0360.20 142621
**
(,75%) (1870–2450) (44–50) (30.00–31.00) (1.80–2.20) (127–166)
Overall mean
b 342 34366477 5563 33.9661.42 2.1160.21 100613
(1870–4700) (44–64) (30.00–39.00) (1.60–3.12) (75–166)
aSeverity was defined as non-case ($85%), mild (80–84.99%), moderate (75–79.99%), and severe (,75%) [46].
bSample size is reduced from 344 to 342 because two newborns had gestational age of 43 and 29 weeks, which fell outside the plausible range [34].
**Test of linear trend with increasing severity of FGR, p,0.001.
doi:10.1371/journal.pone.0035464.t002
Figure 1. The observed and predicted individual gestational S8 c-PAH exposure using semi-parametric mixed effects model
a. a.
Black, open circle represents the observed concentration of S8 c-PAHs. Black line represents the pooled cohort mean during the entire monitoring
period. Three persons were randomly selected to demonstrate estimated personal S8 c-PAHs exposure during her entire pregnancy period (in color).
Based on the semi-parametric mixed effects model, Pearson’s correlation coefficients between observed vs. predicted prenatal exposure were 0.91,
0.98 and 0.96 for the third, sixth and the eighth month.
doi:10.1371/journal.pone.0035464.g001
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35464Our present observation of the largest unit effect during the first
trimester suggests that PAHs might influence the rate of fetal
growth. Other epidemiologic investigations independently ob-
served that fetal growth rate is programmed during the earliest
gestational period, resulting in a progressively larger deficit as
gestation matures [18,19,20].
An adverse intrauterine environment, particularly during the
early pregnancy period, is hypothesized to switch on the survival
mechanism of the fetus by protecting vital organs such as brain
and heart while suppressing the development of other systems
[41]. Recent clinical examinations in various populations have
demonstrated that a significantly slower growth rate begins in the
Figure 2. Mixed Effects Model Estimated ln-unit S8 C-PAH Exposure and Their Effects on Fetal Growth Ratio. The ln S8 c-PAHs effects
on FGR was estimated as a mean effect per trimester-wise exposure and 95% confidence interval.
doi:10.1371/journal.pone.0035464.g002
Figure 3. Semi-Parametric Mixed Model Estimated ln-Unit S8 C-PAH Exposure and Their Point-Wise Effects on Fetal Growth Ratio.
Exposure was estimated using semi-parametric mixed effects model. Figure shows continuous, point-wise effect throughout the trimester based on
functional linear model. The bold line shows regression coefficient per natural-log (ln) unit exposure to airborne PAHs. The dotted lines show point-
wise 95% confidence interval.
doi:10.1371/journal.pone.0035464.g003
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[18,19,20]. Among a group of singleton newborns who were
longitudinally followed from the 12
th week of gestation to delivery
by ultrasound, a significant difference in inter-individual rate of
fetal growth was evident in terms of fetal abdominal and head
circumference, as well as femur diaphysis length [20]. Starting
around the 13
th week, significantly slower fetal growth velocity was
evident for those who were born in the lowest third percentile of
birth weight. This difference in fetal growth velocity remained
constant throughout gestation after maternal anthropomorphic
characteristics (including pre-pregnancy weight, height and weight
gain) were accounted for [20].
Table 3. Non-parametric markers of ambient PAH concentration during various gestational periods and birth outcomes
a.
Nonparametric markers of
ambient PAH concentration
during various gestational
periods Birthweight Birth Length
Birth head
circumference Fetal Growth Ratio Ponderal Index
Cephalization
Index
(n=344) (n=344) (n=344) (n=340) (n=344) (n=344)
R
2=0.461 R
2=0.348 R
2=0.275 R
2=0.093 R
2=0.018 R
2=0.505
[g] reduction
from the mean
(95% CI)
[cm] reduction
from the mean
(95% CI)
[cm] reduction
from the mean
(95% CI)
[%] reduction
from the mean
(95% CI)
[g/cm
36100]
reduction from the
mean (95% CI)
[mm/g]
reduction
from the
mean (95% CI)
Season during 1
st month
(winter vs. other)
b
2191 (2316, 267) 21.14 (21.93, 20.35) 20.38 (20.80, 0.03) 25.37 (28.92, 21.82) 0.02 (20.05, 0.08) 5 (1, 8)
Season during 3
rd month
(winter vs. other)
b
2122 (2226, 217) 20.62 (21.29, 0.05) 20.37 (20.72, 20.02) 23.04 (26.06, 20.03) 0.00 (20.06, 0.06) 3 (0, 6)
Directly monitored personal
c-PAH exposure, second
trimester
c
267 (2110, 223) 20.48 (20.76, 20.20) 20.20 (20.34, 20.05) 21.85 (23.09, 20.60) 0.01 (20.01, 0.04) 1 (0, 3)
Season during 9
th month
(winter vs. other)
b
240 (2148, 68) 20.36 (21.05, 0.33) 20.05 (20.41, 0.32) 20.69 (23.78, 2.39) 0.02 (20.04, 0.08) 1 (22, 4)
aModel controls for gestational age (centered at mean and square term of the centered at mean), newborn gender, parity, and the mother’s pre-pregnancy body mass
index. C-section delivery is included only for the head circumference.
bTo reduce multicollinearity in the models, the indicator variable was coded as the winter vs. other.
cDirect measurement of personal exposure was determined using a personal monitor for 48-hour period. The exposure variable was coded in natural-log scale.
doi:10.1371/journal.pone.0035464.t003
Figure 4. Mixed Effects Model Estimated ln-unit S8 C-PAH Exposure and Their Effects on Cephalization Index. The ln S8 c-PAHs effects
on the outcome was estimated as a mean effect per trimester-wise exposure and 95% confidence interval.
doi:10.1371/journal.pone.0035464.g004
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35464In some populations, fetuses that are born small-for-gestational
age or with low birthweight, are at greater risk of neurodevelop-
mental delays [28], impaired lung function [42], asthma symptoms
[43] throughout childhood, as well as cardiopulmonary diseases
[41] during adulthood, including hypertension, and atherosclero-
sis, as well as diabetes [44]. Our personal, indoor, and outdoor air
monitoring of 344 women represents one of the largest and most
comprehensive PAH exposure assessment campaigns to date. The
airborne PAH exposure in Krakow, Poland, represents a typical
exposure scenario in countries dependent on coal-burning for heat
and power generation [24]. Ambient PAH concentrations differ by
more than two orders of magnitude between summer and winter
with overall spatial homogeneity in concentration during given
season [24]. The extreme seasonal fluctuation of ambient PAH
Figure 5. Semi-Parametric Mixed Model Estimated ln-Unit S8 C-PAH Exposure and Their Point-Wise Effects on Cephalization Index.
Exposure was estimated using semi-parametric mixed effects model. Figure shows continuous, point-wise effect throughout the trimester based on
functional linear model. The bold line shows regression coefficient per natural-log (ln) unit exposure to airborne PAHs. The dotted lines show point-
wise 95% confidence interval.
doi:10.1371/journal.pone.0035464.g005
Figure 6. Mixed Effects Model Estimated ln-unit S8 C-PAH Exposure and Their Effects on Ponderal Index. The ln S8 c-PAHs effects on
the outcome was estimated as a mean effect per trimester-wise exposure and 95% confidence interval.
doi:10.1371/journal.pone.0035464.g006
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personal PAH exposure concentrations during the unmonitored
months. Spearman’s coefficients for concurrent personal, indoor
and outdoor measurements ranged between 0.96–0.98 [25]. Thus,
the spatial variability in personal, indoor and outdoor PAH
concentration (within a given household) was very small during a
typical air pollution episode (Figure 1). For example, the
maximum values for personal B[a]P exposure concentration
(42.23 ng/m
3) in our cohort and ambient B[a]P level (200 ng/
m
3), as reported by Junninen et al. (2009), represent two of the
highest values of the compound that have ever been documented.
Accordingly, the cohort’s mean exposure over the monitoring
period was weighed heavily in estimating the personal exposure of
other newborns during their unmonitored months. Pearson’s
correlation coefficients between observed vs. predicted personal
exposure concentration were 0.91, 0.98, and 0.96 at the 3
rd,6
th,
and 8
th gestational month, respectively.
Another key strength of the study is the application of stringent
enrollment criteria. Only young Polish women (18–35 years of
age), non-smoking, healthy (i.e., free of diabetes, hypertension, or
known HIV, nonusers of other tobacco products or illicit drugs)
were targeted. In addition, only those who received adequate
prenatal care (i.e. enrolled in the clinic between 8
th to 13
th week of
pregnancy) were included. Thus, several important confounders
have been precluded. At the same time, several study limitations
warrant consideration. As our strict enrollment criteria precluded
notable sources of confounding, our mothers and newborns cohort
is not representative of the general population. Furthermore, only
those fetuses who survived beyond the 8–13
th gestational weeks
were recruited into the study. Thus, PAH effects in the general
population might be different than in the present cohort.
It is currently unknown whether other constituents of coal
combustion by-products, including Cadmium (Cd), Nickel (Ni),
Arsenic (As), and Lead (Pb) affect birth outcomes through a
mechanism common with PAHs. Thus, our results cannot rule out
confounding effects from other airborne correlates of PAHs,
particularly during the winter. Another limitation of the study is
the fact that we did not consider the genetic polymorphisms of the
developing fetus and/or the mothers for the risk of IUGR. In our
earlier analyses, both maternal and newborn haplotypes of the
cytochrome 450 genes CYP1A1 significantly augmented PAH
effects on children’s neurocognitive development once they
reached the age of 1, 2, and 3 respectively [45]. It is plausible
that the genes involved in PAH metabolic activation or
detoxification may also modify PAH exposure risks on IUGR.
Cyclic fluctuation in ambient PAH concentration influenced the
mean personal exposure during the first gestational month so that
it was positively correlated with exposure during the ninth
gestational month. While we statistically adjusted for this
correlation in exposure, future research should quantify the fetal
growth rate in real-time during gestation, rather than determine
the absolute size decrement at birth. Such a measurement would
also be useful in early detection of IUGR cases.
Conclusion
The identification of a ‘‘window of critical vulnerability’’ to
ubiquitous air pollutants such as PAHs is a particularly important,
yet challenging, question. The challenge surrounding this question
stems, at least partly, from the fact that the dose-response
relationship of the xenotoxicant during a given age is inherently
related to the host’s susceptibility as well as the host’s adaptiveness.
Furthermore, exposure duration is chronic, yet variable. Our
results based on several alternate exposure estimation approaches
suggest that one ln-unit PAH exposure during the first trimester,
and the first gestational month in particular, increases the risk of
FGR reduction and Cephalization Index elevation, respectively.
On the other hand, no gestational period was associated with a
marked reduction in Ponderal index. Reduction in birthweight,
birth length and FGR, as well as an elevated CI predict mortality
and morbidity risks in newborns and compromised cognitive
development in children. In addition, ambient PAH concentra-
tions in Krakow are typical of regions dependent on coal-burning
for heat and power generation [24]. The present data support the
need for a multinational coal-combustion abatement strategy for
the protection of pregnant women and the embryo/fetus,
particularly during the earliest stage of pregnancy.
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